The Centers for Disease Control and Prevention (CDC) finds itself at the center of a growing controversy as the United States faces its worst measles resurgence in decades. With vaccination rates declining and respiratory illnesses like flu, COVID-19, and RSV resurging, public health experts are increasingly worried about the reliability of health information from the federal agency.
Dr. Demetre Daskalakis former director of the National Center for Immunization and Respiratory Diseases at the CDC, resigned last year citing political interference. He now raises a red flag about the agency’s handling of two measles-related deaths in Pennsylvania, where Health and Human Services Secretary Robert F. Kennedy Jr. questioned the state’s findings, leading the CDC to remove the deaths from its website.
Breaking down trust between states and federal health officials
The CDC typically defers to state determinations when it comes to disease-related deaths. However, Kennedy’s public dispute with Pennsylvania officials and the CDC’s subsequent removal of the deaths from its website have raised serious concerns about the relationship between state and federal health authorities.
Dr. Anne Zink senior fellow at the Yale School of Public Health, notes that this incident amplifies existing tensions. ‘What we have been seeing… is a breakdown in the coordination and trust between states and the federal government,’ she states. This erosion of trust is particularly troubling given the critical role these partnerships play in public health.
Questions about the reliability of federal health data
Experts are now questioning whether the public can trust federal health data about measles and other diseases. There are concerns that the CDC might suppress information to downplay the impact of falling immunization rates, especially considering Kennedy’s history of questioning vaccines.
Dr. Georges Benjamin head of the American Public Health Association, emphasizes the importance of reliable data. ‘We need to have good solid evidence-based national data,’ he says. ‘If it happens with flu and with COVID, the question is: Who can we rely on for the data on a national level?’
The challenge facing the new CDC director
The controversy comes at a challenging time for the CDC’s new director, Dr. Erica Schwartz who took over after a tumultuous year that left the agency demoralized. Many had hoped Schwartz would restore the CDC’s morale and credibility by pushing back against political pressure. However, the agency’s handling of the Pennsylvania measles cases has raised doubts about her ability to do so.
Daskalakis describes the current situation as ‘a pretty compromised CDC,’ with the director at best facilitating non-scientific behavior and at worst colluding with it. Dr. Debra Houry former CDC chief medical officer, agrees, stating that Schwartz should be focusing on responding to outbreaks rather than questioning disease counts.
As the measles resurgence continues and vaccination rates fall, the CDC faces significant challenges in restoring public trust and effectively responding to public health threats. The agency’s ability to provide reliable data and maintain strong partnerships with state health officials will be crucial in navigating these difficult times.
